Skip to main content
OpenTrials

Clinical trial condition

Uveal Melanoma

Explore clinical trials studying Uveal Melanoma. Study availability and eligibility vary by location and protocol.

201 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Uveal Melanoma trial results

Completed

Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma

NCT02626962

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +14 more
Locations
  • Hospital Son Espases Palma de Mallorca, Balearic Islands, Spain
  • ICO Hospitalet L'Hospitalet de Llobregat, Spain
  • H. Insular de Canarias Las Palmas de Gran Canaria, Spain
  • Hospital La Paz Madrid, Spain
View Trial Details
Completed

A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma

NCT02129075

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +25 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
  • Mount Sinai Hospital New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

NCT00324727

Conditions
Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +21 more
Locations
  • John Wayne Cancer Institute at Saint John's Health Center Santa Monica, California, United States
  • Swedish Medical Center Englewood, Colorado, United States
  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
  • Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
View Trial Details
Completed

Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients

NCT01430416

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +15 more
Locations
  • Dana Farber Cancer Institute DFCI - Brookline Boston, Massachusetts, United States
  • Memorial Sloan Kettering MSKCC 4 New York, United States
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Leiden, Netherlands
View Trial Details
Completed

Glembatumumab Vedotin in Treating Patients With Metastatic or Locally Recurrent Uveal Melanoma

NCT02363283

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +13 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 25 locations
View Trial Details

Related conditions